Literature DB >> 17716838

Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers.

Shixia Feng1, Sunil Kapur, Mohamadi Sarkar, Raheema Muhammad, Paul Mendes, Kirk Newland, Hans J Roethig.   

Abstract

Urinary excretion of nicotine and its five major metabolites (nicotine-N-glucuronide, cotinine, cotinine-N-glucuronide, trans-3'-hydroxycotinine, and trans-3'-hydroxycotinine-O-glucuronide), expressed as nicotine equivalents (NE), has been used as a biomarker of smoking-related nicotine exposure. In this open-label, single center study, we investigated the relationship between nicotine retention from smoking and urinary excretion of NE in adult smokers. After a 4-day washout period, 16 adult male smokers smoked 6 cigarettes per day for four consecutive days according to three predefined smoking patterns: no inhalation (Pattern A), normal inhalation (Pattern B), and deep inhalation (Pattern C). The amount of nicotine retained in the respiratory tract during smoking was estimated from the difference between the amounts of nicotine delivered and exhaled. The daily excretion of urinary NE was measured in 24h urine samples by LC-MS/MS. The mean (+/-S.D.) amount of nicotine retained was 0.126+/-0.167, 0.960+/-0.214, and 1.070+/-0.223mg/cig for Patterns A, B, and C, respectively. The mean (+/-S.D.) relative retention (the amount retained relative to the amount delivered) was 11.2+/-14.7%, 98.0+/-1.6%, and 99.6+/-0.3% for Patterns A, B, and C, respectively. On the fourth day of smoking, an average of 86+/-20% of the total daily amount of retained nicotine was recovered as NE in 24h urine. Nicotine equivalents was treated as a single component and the data was described by a first-order elimination pharmacokinetic model which assumed instantaneous input and distribution. Based on this model, the elimination half-life of NE was 19.4+/-2.6h, and the NE excretion had reached approximately 96% of the steady state levels by Day 4. Our results suggest that most of the nicotine inhaled from a cigarette is retained (> or =98%) in the lung, and at steady state, daily urine NE excretion reflects approximately 90% of the retained nicotine dose from cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716838     DOI: 10.1016/j.toxlet.2007.06.016

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  20 in total

1.  Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.

Authors:  Neal L Benowitz; Katherine M Dains; Delia Dempsey; Lisa Yu; Peyton Jacob
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

2.  A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine.

Authors:  Taraneh Taghavi; Maria Novalen; Caryn Lerman; Tony P George; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-31       Impact factor: 4.254

Review 3.  Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se.

Authors:  Hans-Juergen Haussmann; Marc W Fariss
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

Review 4.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

5.  Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers.

Authors:  Gideon St Helen; Maciej L Goniewicz; Delia Dempsey; Margaret Wilson; Peyton Jacob; Neal L Benowitz
Journal:  Chem Res Toxicol       Date:  2012-03-29       Impact factor: 3.739

6.  Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure.

Authors:  Gideon St Helen; Delia Dempsey; Margaret Wilson; Peyton Jacob; Neal L Benowitz
Journal:  Addiction       Date:  2012-11-01       Impact factor: 6.526

7.  UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.

Authors:  Catherine A Wassenaar; David V Conti; Soma Das; Peixian Chen; Edwin H Cook; Mark J Ratain; Neal L Benowitz; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

8.  Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.

Authors:  Taku Nagano; Makiko Shimizu; Kazuma Kiyotani; Tetsuya Kamataki; Ryohji Takano; Norie Murayama; Fumiaki Shono; Hiroshi Yamazaki
Journal:  Int J Environ Res Public Health       Date:  2010-07-20       Impact factor: 3.390

9.  Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling.

Authors:  Hiroshi Yamazaki; Kana Horiuchi; Ryohji Takano; Taku Nagano; Makiko Shimizu; Masato Kitajima; Norie Murayama; Fumiaki Shono
Journal:  Int J Environ Res Public Health       Date:  2010-09-01       Impact factor: 3.390

10.  Maternal personal exposure to airborne benzene and intrauterine growth.

Authors:  Rémy Slama; Olivier Thiebaugeorges; Valérie Goua; Lucette Aussel; Paolo Sacco; Aline Bohet; Anne Forhan; Béatrice Ducot; Isabella Annesi-Maesano; Joachim Heinrich; Guillaume Magnin; Michel Schweitzer; Monique Kaminski; Marie-Aline Charles
Journal:  Environ Health Perspect       Date:  2009-04-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.